HER2 Low Breast Cancer: New Clinical Entity or Testing Artifact
Should breast cancer patients with low but not negative tumor expression of HER2 be considered a distinct patient group that can be treated differently from patients with tumors that are HER2 negative or HER2 positive? That was the question posed during a session at the recent San Antonio Breast Cancer Symposium (SABCS) 2022.Source: Medscape
Yale Cancer Center Study Characterizes Link Between Drug Resistance and Central Nervous System Relapse
A new study from Yale Cancer Center characterizes the functional link between drug resistance and central nervous system (CNS) relapse. The findings from a study led by Don Nguyen, PhD, BS, Associate Professor of Pathology and Medicine (Medical Oncology) and Assistant Yale Cancer Center Director for Research Development, were recently published in the journal Nature Communications.
Patient Selection for AstraZeneca, Daiichi Breast Cancer Drug Needs Improvement, Experts Say
The rush to use AstraZeneca and Daiichi-Sankyo’s drug Enhertu to treat certain types of breast cancer has far outpaced doctors’ ability to determine with certainty which patients might benefit, experts said this week at a meeting of breast cancer doctors.Source: Financial Post
Spatial and Single Cell Characterization of Breast Cancer Progression: Presenter Profile
Presentation is about methods for assessment of multiple molecular variables on a single piece of tissue to better understand breast cancer (or really any cancer) with respect to progression or response or resistance to specific therapies.Source: SABCS Meeting News
Yale Pathologists to Collaborate with African Physicians at Inaugural PEACE Symposium
A partnership that began at Emory University to allow pathologists to collaborate and share knowledge with physicians in Africa has expanded to include Yale School of Medicine pathologists and will hold its first symposium in December.
Yale Researchers Awarded $12M NIH Grant to Study Impact of FGF21 Protein on Aging
Researchers from Yale University, and the University of Texas Southwestern Medical Center have been awarded a $12.4 million, five-year grant from the National Institute on Aging of the NIH to deploy their unique research models and expertise in a coordinated fashion to develop a novel course of gerontological research.
Dhanpat Jain, MD, Joins Pathologists Nationwide in Calling for Continued Use of Remote Work in Clinical Laboratories and Pathology
A group of pathologists and laboratory leaders from across the U.S. is urging federal officials to continue certain regulatory exemptions implemented during the COVID-19 pandemic that allow the use of remote work in clinical laboratories and pathology.
Two Yale Pathology Faculty Among 12 Honored with 2022 Yale Faculty Innovation Awards
Two Yale Pathology professors were among 12 faculty members honored with 2022 Yale Faculty Innovation Awards, which recognize the significant contributions of Yale faculty who develop new technologies and launch startups that address global challenges.
Yale Pathology Offers Anatomic Pathology and Anatomic Pathology/Laboratory Medicine Electives
The Yale Pathology section of Anatomic Pathology offers an elective to medical students in their third or fourth year at Yale School of Medicine that provides a broad experience in general diagnostic techniques.
ExPath Grad Student Madeline Mayday Awarded Grant from the NIDDK Cooperative Centers of Excellence in Hematology
Madeline Mayday, BS, a fourth-year Experimental Pathology graduate student in the Laboratory of Diane Krause, MD, PhD, was recently awarded a 2022 National Institute of Diabetes and Digestive and Kidney Diseases Hematology Centers Program Type B Pilot and Feasibility grant
American Joint Committee on Cancer Names Dhanpat Jain, MD, to Editorial Board
Dhanpat Jain, MD, Professor of Pathology and of Medicine (Digestive Diseases), has been named by the American Joint Committee on Cancer (AJCC) to its editorial board for neuroendocrine tumors of the gastrointestinal tract.
Marie Robert, MD, Jordan Pober, MD, PhD, Awarded POINTS Grant to Study Pathogenesis of Celiac Disease
Marie Robert, MD, Professor of Pathology and of Medicine (Digestive Diseases), and Jordan Pober, MD, PhD, the Bayer Professor of Translational Medicine and Professor of Immunobiology, Pathology, and Dermatology, have been awarded a grant from the Program for the Promotion of Interdisciplinary Team Science (POINTS) at Yale School of Medicine to study the Pathogenesis of Celiac Disease.
Cancer Research Institute To Host Second-Annual Spanish-Language Virtual Immunotherapy Patient Summit, Moderated By Ana Patricia Gámez, To Connect The U.S. Hispanic Cancer Community With Information That Can Save Lives
The Cancer Research Institute (CRI), a nonprofit organization spearheading transformative research to harness the immune system's power to control and potentially cure all cancers, will offer its second annual CRI Virtual Immunotherapy Patient Summit in Spanish on September 22, 2022, 2-5 p.m. ET. This free virtual event, moderated by TV Host and Entrepreneur Ana Patricia Gámez, and presented completely in Spanish, will connect Hispanic cancer patients and caregivers with groundbreaking research updates from leading immunotherapy experts driving scientific breakthroughs and advancements that impact patient care.Source: PR Newswire
Yale Pathologists Say AI, Algorithms in Digital Pathology Will Have Lasting Impact on Education, Clinical Practice
The continued emergence and development of artificial intelligence and algorithms in digital pathology will greatly impact the practice and teaching of pathology, Angelique W. Levi, MD, Associate Professor of Pathology, and Sudhir Perincheri, MBBS, PhD, Assistant Professor of Pathology, said in a recent podcast.